BioHarvest Sciences Inc. Common Stock
BHST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 98.8% | 130.5% | 161.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 55.4% | 44.5% | 22.2% | 31.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -38.6% | -77% | -166% | -410.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -51.3% | -99.1% | -204.4% | -467.5% |
| EPS Diluted | -0.8 | -0.93 | -0.7 | -0.7 |
| % Growth | 14% | -32.9% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |